Ls Investment Advisors, LLC Gilead Sciences, Inc. Transaction History

Ls Investment Advisors, LLC

$656 Million
Q3 2024

16 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 11, 2021	SELL	$63.47 - $69.35 $3.04 Million - $3.32 Million	-47,829 Closed	0 $0
Q1 2021 May 13, 2021	SELL	$60.0 - $68.46 $843,780 - $962,752	-14,063 Reduced 22.72%	47,829 $3.09 Million
Q4 2020 Feb 10, 2021	BUY	$56.65 - $64.55 $106,558 - $121,418	1,881 Added 3.13%	61,892 $3.61 Million
Q3 2020 Nov 12, 2020	BUY	$62.1 - $78.08 $218,219 - $274,373	3,514 Added 6.22%	60,011 $3.79 Million
Q2 2020 Aug 10, 2020	SELL	$72.34 - $84.0 $3.36 Million - $3.9 Million	-46,433 Reduced 45.11%	56,497 $4.35 Million
Q1 2020 Apr 20, 2020	SELL	$62.63 - $80.22 $363,880 - $466,078	-5,810 Reduced 5.34%	102,930 $7.7 Million
Q4 2019 Jan 31, 2020	SELL	$61.62 - $67.78 $44,181 - $48,598	-717 Reduced 0.66%	108,740 $7.07 Million
Q3 2019 Oct 31, 2019	SELL	$62.51 - $69.0 $55,508 - $61,272	-888 Reduced 0.8%	109,457 $6.94 Million
Q2 2019 Aug 07, 2019	SELL	$61.87 - $69.38 $20,973 - $23,519	-339 Reduced 0.31%	110,345 $7.46 Million
Q1 2019 Apr 25, 2019	SELL	$62.53 - $70.05 $148,383 - $166,228	-2,373 Reduced 2.1%	110,684 $7.2 Million
Q4 2018 Feb 01, 2019	SELL	$60.54 - $79.0 $439,459 - $573,461	-7,259 Reduced 6.03%	113,057 $7.07 Million
Q3 2018 Nov 13, 2018	SELL	$71.28 - $78.92 $185,898 - $205,823	-2,608 Reduced 2.12%	120,316 $9.29 Million
Q2 2018 Jul 20, 2018	SELL	$64.88 - $75.68 $520,013 - $606,575	-8,015 Reduced 6.12%	122,924 $8.71 Million
Q1 2018 May 08, 2018	SELL	$72.84 - $88.8 $389,329 - $474,636	-5,345 Reduced 3.92%	130,939 $9.87 Million
Q4 2017 Feb 07, 2018	SELL	$71.15 - $83.52 $7,043 - $8,268	-99 Reduced 0.07%	136,284 $9.76 Million
Q3 2017 Oct 19, 2017	BUY	$72.11 - $85.47 $9.83 Million - $11.7 Million	136,383	136,383 $11.1 Million

Others Institutions Holding GILD

# of Institutions

1,927

Shares Held

994M

Call Options Held

10.5M

Put Options Held

9.75M

Black Rock Inc. New York, NY

121M
Shares

$11.1 Billion
0.19% of portfolio
Vanguard Group Inc Valley Forge, PA

115M
Shares

$10.7 Billion
0.18% of portfolio
Capital World Investors Los Angeles, CA

76.5M
Shares

$7.07 Billion
1.03% of portfolio
Capital Research Global Investors Los Angeles, CA

61.8M
Shares

$5.71 Billion
1.12% of portfolio
State Street Corp Boston, MA

60.2M
Shares

$5.56 Billion
0.21% of portfolio

View Full List

About GILEAD SCIENCES, INC.

Ticker GILD
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 1,253,369,984
Market Cap $116B
Description
Gilead Sciences, Inc., a biopharmaceutical company, discovers, develops, and commercializes medicines in the areas of unmet medical need in the United States, Europe, and internationally. The company provides Biktarvy, Genvoya, Descovy, Odefsey, Truvada, Complera/ Eviplera, Stribild, and Atripla products for the treatment of HIV/AIDS; Veklury, a...

More about GILD

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Ls Investment Advisors, LLC, based on Form 13F filings with the SEC.

News

Stay updated on Ls Investment Advisors, LLC with notifications on news.

Account